1
|
Horne A, Abravan A, Fornacon-Wood I, O’Connor JPB, Price G, McWilliam A, Faivre-Finn C. Mastering CT-based radiomic research in lung cancer: a practical guide from study design to critical appraisal. Br J Radiol 2025; 98:653-668. [PMID: 40100283 PMCID: PMC12012345 DOI: 10.1093/bjr/tqaf051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2024] [Revised: 12/18/2024] [Accepted: 02/25/2025] [Indexed: 03/20/2025] Open
Abstract
Radiomics is a health technology that has the potential to extract clinically meaningful biomarkers from standard of care imaging. Despite a wealth of exploratory analysis performed on scans acquired from patients with lung cancer and existing guidelines describing some of the key steps, no radiomic-based biomarker has been widely accepted. This is primarily due to limitations with methodology, data analysis, and interpretation of the available studies. There is currently a lack of guidance relating to the entire radiomic workflow from study design to critical appraisal. This guide, written with early career lung cancer researchers, describes a more complete radiomic workflow. Lung cancer image analysis is the focus due to some of the unique challenges encountered such as patient movement from breathing. The guide will focus on CT imaging as these are the most common scans performed on patients with lung cancer. The aim of this article is to support the production of high-quality research that has the potential to positively impact outcome of patients with lung cancer.
Collapse
Affiliation(s)
- Ashley Horne
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
- Department of Thoracic Oncology, The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom
| | - Azadeh Abravan
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
| | - Isabella Fornacon-Wood
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
| | - James P B O’Connor
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
- Division of Radiotherapy and Imaging, Institute of Cancer Research, London, SW7 3RP, United Kingdom
| | - Gareth Price
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
| | - Alan McWilliam
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
| | - Corinne Faivre-Finn
- Division of Cancer Sciences, The University of Manchester, Manchester, M13 9NT, United Kingdom
- Department of Thoracic Oncology, The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom
| |
Collapse
|
2
|
Zong R, Ma X, Shi Y, Geng L. Can Machine Learning Models Based on Computed Tomography Radiomics and Clinical Characteristics Provide Diagnostic Value for Epstein-Barr Virus-Associated Gastric Cancer? J Comput Assist Tomogr 2024; 48:859-867. [PMID: 38924393 DOI: 10.1097/rct.0000000000001636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/28/2024]
Abstract
OBJECTIVE The aim of this study was to explore whether machine learning model based on computed tomography (CT) radiomics and clinical characteristics can differentiate Epstein-Barr virus-associated gastric cancer (EBVaGC) from non-EBVaGC. METHODS Contrast-enhanced CT images were collected from 158 patients with GC (46 EBV-positive, 112 EBV-negative) between April 2018 and February 2023. Radiomics features were extracted from the volumes of interest. A radiomics signature was built based on radiomics features by the least absolute shrinkage and selection operator logistic regression algorithm. Multivariate analyses were used to identify significant clinicoradiological variables. We developed 6 ML models for EBVaGC, including logistic regression, Extreme Gradient Boosting, random forest (RF), support vector machine, Gaussian Naive Bayes, and K-nearest neighbor algorithm. The area under the receiver operating characteristic curve (AUC), the area under the precision-recall curves (AP), calibration plots, and decision curve analysis were applied to assess the effectiveness of each model. RESULTS Six ML models achieved AUC of 0.706-0.854 and AP of 0.480-0.793 for predicting EBV status in GC. With an AUC of 0.854 and an AP of 0.793, the RF model performed the best. The forest plot of the AUC score revealed that the RF model had the most stable performance, with a standard deviation of 0.003 for AUC score. RF also performed well in the testing dataset, with an AUC of 0.832 (95% confidence interval: 0.679-0.951), accuracy of 0.833, sensitivity of 0.857, and specificity of 0.824, respectively. CONCLUSIONS The RF model based on clinical variables and Rad_score can serve as a noninvasive tool to evaluate the EBV status of gastric cancer.
Collapse
Affiliation(s)
- Ruilong Zong
- From the Department of Radiology, Xuzhou Central Hospital, Xuzhou, China
| | - Xijuan Ma
- From the Department of Radiology, Xuzhou Central Hospital, Xuzhou, China
| | - Yibing Shi
- From the Department of Radiology, Xuzhou Central Hospital, Xuzhou, China
| | - Li Geng
- Department of Radiology, The Affiliated Hospital of Xuzhou Medical University
| |
Collapse
|
3
|
Ismail M, Hanifa MAM, Mahidin EIM, Manan HA, Yahya N. Cone beam computed tomography (CBCT) and megavoltage computed tomography (MVCT)-based radiomics in head and neck cancers: a systematic review and radiomics quality score assessment. Quant Imaging Med Surg 2024; 14:6963-6977. [PMID: 39281127 PMCID: PMC11400681 DOI: 10.21037/qims-24-334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2024] [Accepted: 06/27/2024] [Indexed: 09/18/2024]
Abstract
Background Cone beam computed tomography (CBCT) and megavoltage computed tomography (MVCT)-based images demonstrate measurable radiomics features that are potentially prognostic. This study aims to systematically synthesize the current research applying radiomics in head and neck cancers for outcome prediction and to assess the radiomics quality score (RQS) of the studies. Methods A systematic search was performed to identify available studies on PubMed, Web of Science, and Scopus databases. Studies related to radiomics in oncology/radiotherapy fields and based on predefined Patient, Intervention, Comparator, Outcome, and Study design (PICOS) criteria were included. The methodological quality of the included study was evaluated independently by two reviewers according to the RQS. The Mann-Whitney U test was performed according to subgroups. The P values <0.05 were considered statistically significant. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 reporting guidelines were adhered to. Results From a total of 743 identified studies, six original studies were eligible for inclusion in the systematic review (median =97 patients). The intraclass correlation coefficient (ICC) for inter-reviewer on total RQS was excellent with 0.99 [95% confidence interval (CI) of 0.946< ICC <0.999]. There were no significant differences in the analyses between each RQS domain and subgroup components (P always >0.05). Numerically higher RQS domains score for publication year ≤2022 than 2023 and number of patients > median than ≤ median but not statistically significant. Conclusions The number of radiomics studies involving CBCT and MVCT is still very limited. Self-reported RQS assessments should be encouraged for all radiomics studies.
Collapse
Affiliation(s)
- Mahayu Ismail
- Faculty of Health Sciences, National University of Malaysia, Jalan Raja Muda Aziz, Kuala Lumpur, Malaysia
- Department of Radiotherapy and Oncology, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur, Malaysia
| | - Mohd Ariff Mohamed Hanifa
- Department of Radiotherapy and Oncology, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur, Malaysia
| | - Eznal Izwadi Mohd Mahidin
- Department of Radiotherapy and Oncology, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur, Malaysia
| | - Hanani Abdul Manan
- Functional Image Processing Laboratory, Department of Radiology, Universiti Kebangsaan Malaysia Medical Centre, Cheras, Kuala Lumpur, Malaysia
| | - Noorazrul Yahya
- Faculty of Health Sciences, National University of Malaysia, Jalan Raja Muda Aziz, Kuala Lumpur, Malaysia
| |
Collapse
|
4
|
Pistel M, Brock L, Laun FB, Erber R, Weiland E, Uder M, Wenkel E, Ohlmeyer S, Bickelhaupt S. Stability of Radiomic Features against Variations in Lesion Segmentations Computed on Apparent Diffusion Coefficient Maps of Breast Lesions. Diagnostics (Basel) 2024; 14:1427. [PMID: 39001317 PMCID: PMC11241112 DOI: 10.3390/diagnostics14131427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Revised: 06/18/2024] [Accepted: 06/24/2024] [Indexed: 07/16/2024] Open
Abstract
Diffusion-weighted imaging (DWI) combined with radiomics can aid in the differentiation of breast lesions. Segmentation characteristics, however, might influence radiomic features. To evaluate feature stability, we implemented a standardized pipeline featuring shifts and shape variations of the underlying segmentations. A total of 103 patients were retrospectively included in this IRB-approved study after multiparametric diagnostic breast 3T MRI with a spin-echo diffusion-weighted sequence with echoplanar readout (b-values: 50, 750 and 1500 s/mm2). Lesion segmentations underwent shifts and shape variations, with >100 radiomic features extracted from apparent diffusion coefficient (ADC) maps for each variation. These features were then compared and ranked based on their stability, measured by the Overall Concordance Correlation Coefficient (OCCC) and Dynamic Range (DR). Results showed variation in feature robustness to segmentation changes. The most stable features, excluding shape-related features, were FO (Mean, Median, RootMeanSquared), GLDM (DependenceNonUniformity), GLRLM (RunLengthNonUniformity), and GLSZM (SizeZoneNonUniformity), which all had OCCC and DR > 0.95 for both shifting and resizing the segmentation. Perimeter, MajorAxisLength, MaximumDiameter, PixelSurface, MeshSurface, and MinorAxisLength were the most stable features in the Shape category with OCCC and DR > 0.95 for resizing. Considering the variability in radiomic feature stability against segmentation variations is relevant when interpreting radiomic analysis of breast DWI data.
Collapse
Affiliation(s)
- Mona Pistel
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
- Siemens Healthineers AG, 91052 Erlangen, Germany
| | - Luise Brock
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
| | - Frederik Bernd Laun
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
| | - Ramona Erber
- Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
| | - Elisabeth Weiland
- MR Application Predevelopment, Siemens Healthineers AG, 91052 Erlangen, Germany
| | - Michael Uder
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
| | - Evelyn Wenkel
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
- Radiologie München, 80331 München, Germany
| | - Sabine Ohlmeyer
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
| | - Sebastian Bickelhaupt
- Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
| |
Collapse
|
5
|
Veiga-Canuto D, Fernández-Patón M, Cerdà Alberich L, Jiménez Pastor A, Gomis Maya A, Carot Sierra JM, Sangüesa Nebot C, Martínez de las Heras B, Pötschger U, Taschner-Mandl S, Neri E, Cañete A, Ladenstein R, Hero B, Alberich-Bayarri Á, Martí-Bonmatí L. Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma Tumors. Radiol Artif Intell 2024; 6:e230208. [PMID: 38864742 PMCID: PMC11294951 DOI: 10.1148/ryai.230208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2023] [Revised: 04/22/2024] [Accepted: 05/30/2024] [Indexed: 06/13/2024]
Abstract
Purpose To evaluate the reproducibility of radiomics features extracted from T2-weighted MR images in patients with neuroblastoma. Materials and Methods A retrospective study included 419 patients (mean age, 29 months ± 34 [SD]; 220 male, 199 female) with neuroblastic tumors diagnosed between 2002 and 2023, within the scope of the PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers (ie, PRIMAGE) project, involving 746 T2/T2*-weighted MRI sequences at diagnosis and/or after initial chemotherapy. Images underwent processing steps (denoising, inhomogeneity bias field correction, normalization, and resampling). Tumors were automatically segmented, and 107 shape, first-order, and second-order radiomics features were extracted, considered as the reference standard. Subsequently, the previous image processing settings were modified, and volumetric masks were applied. New radiomics features were extracted and compared with the reference standard. Reproducibility was assessed using the concordance correlation coefficient (CCC); intrasubject repeatability was measured using the coefficient of variation (CoV). Results When normalization was omitted, only 5% of the radiomics features demonstrated high reproducibility. Statistical analysis revealed significant changes in the normalization and resampling processes (P < .001). Inhomogeneities removal had the least impact on radiomics (83% of parameters remained stable). Shape features remained stable after mask modifications, with a CCC greater than 0.90. Mask modifications were the most favorable changes for achieving high CCC values, with a radiomics features stability of 70%. Only 7% of second-order radiomics features showed an excellent CoV of less than 0.10. Conclusion Modifications in the T2-weighted MRI preparation process in patients with neuroblastoma resulted in changes in radiomics features, with normalization identified as the most influential factor for reproducibility. Inhomogeneities removal had the least impact on radiomics features. Keywords: Pediatrics, MR Imaging, Oncology, Radiomics, Reproducibility, Repeatability, Neuroblastic Tumors Supplemental material is available for this article. © RSNA, 2024 See also the commentary by Safdar and Galaria in this issue.
Collapse
Affiliation(s)
- Diana Veiga-Canuto
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Matías Fernández-Patón
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Leonor Cerdà Alberich
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Ana Jiménez Pastor
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Armando Gomis Maya
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Jose Miguel Carot Sierra
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Cinta Sangüesa Nebot
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Blanca Martínez de las Heras
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Ulrike Pötschger
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Sabine Taschner-Mandl
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Emanuele Neri
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Adela Cañete
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Ruth Ladenstein
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Barbara Hero
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Ángel Alberich-Bayarri
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| | - Luis Martí-Bonmatí
- From the Grupo de Investigación Biomédica en Imagen, Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106 Torre A planta 7, 46026 Valencia, Spain (D.V.C., M.F.P., L.C.A., A.G.M., L.M.B.); Área Clínica de Imagen Médica (D.V.C., C.S.N., L.M.B.) and Department of Pediatric Oncology (B.M.d.l.H., A.C.), Hospital Universitari i Politècnic La Fe, Valencia, Spain; Quantitative Imaging Biomarkers in Medicine, QUIBIM SL, Valencia, Spain (A.J.P., A.A.B.); Departamento de Estadística e Investigación Operativa Aplicadas y Calidad, Universitat Politècnica de València, Valencia, Spain (J.M.C.S.); St. Anna Children’s Cancer Research Institute, Vienna, Austria (U.P., S.T.M., R.L.); Division of Academic Radiology, Department of Translational Research, University of Pisa, Pisa, Italy (E.N.); and Department of Pediatric Oncology and Hematology, University Children’s Hospital of Cologne, Medical 18 Faculty, University of Cologne, Cologne, Germany (B.H.)
| |
Collapse
|
6
|
Brown KH, Kerr BN, Pettigrew M, Connor K, Miller IS, Shiels L, Connolly C, McGarry C, Byrne AT, Butterworth KT. A comparative analysis of preclinical computed tomography radiomics using cone-beam and micro-computed tomography scanners. Phys Imaging Radiat Oncol 2024; 31:100615. [PMID: 39157293 PMCID: PMC11328005 DOI: 10.1016/j.phro.2024.100615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2024] [Revised: 07/17/2024] [Accepted: 07/20/2024] [Indexed: 08/20/2024] Open
Abstract
Background and purpose Radiomics analysis extracts quantitative data (features) from medical images. These features could potentially reflect biological characteristics and act as imaging biomarkers within precision medicine. However, there is a lack of cross-comparison and validation of radiomics outputs which is paramount for clinical implementation. In this study, we compared radiomics outputs across two computed tomography (CT)-based preclinical scanners. Materials and methods Cone beam CT (CBCT) and µCT scans were acquired using different preclinical CT imaging platforms. The reproducibility of radiomics features on each scanner was assessed using a phantom across imaging energies (40 & 60 kVp) and segmentation volumes (44-238 mm3). Retrospective mouse scans were used to compare feature reliability across varying tissue densities (lung, heart, bone), scanners and after voxel size harmonisation. Reliable features had an intraclass correlation coefficient (ICC) > 0.8. Results First order and GLCM features were the most reliable on both scanners across different volumes. There was an inverse relationship between tissue density and feature reliability, with the highest number of features in lung (CBCT=580, µCT=734) and lowest in bone (CBCT=110, µCT=560). Comparable features for lung and heart tissues increased when voxel sizes were harmonised. We have identified tissue-specific preclinical radiomics signatures in mice for the lung (133), heart (35), and bone (15). Conclusions Preclinical CBCT and µCT scans can be used for radiomics analysis to support the development of meaningful radiomics signatures. This study demonstrates the importance of standardisation and emphasises the need for multi-centre studies.
Collapse
Affiliation(s)
- Kathryn H Brown
- Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
| | - Brianna N Kerr
- Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
| | - Mihaela Pettigrew
- Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
| | - Kate Connor
- Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Ian S Miller
- Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland
- National Preclinical Imaging Centre, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Liam Shiels
- Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Colum Connolly
- Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Conor McGarry
- Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
- Northern Ireland Cancer Centre, Belfast Health & Social Care Trust, Belfast, United Kingdom
| | - Annette T Byrne
- Department of Physiology and Medical Physics and Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin 2, Ireland
- National Preclinical Imaging Centre, Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Karl T Butterworth
- Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom
| |
Collapse
|
7
|
Zhao M, Song X, Ma Y, Li Z, Wang Y, Liu A, Lu H, Ma Y, Ye Z. Accuracy of cone-beam breast computed tomography for assessing breast cancer tumor size-comparison with breast magnetic resonance imaging. Gland Surg 2024; 13:281-296. [PMID: 38601282 PMCID: PMC11002476 DOI: 10.21037/gs-23-401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2023] [Accepted: 01/23/2024] [Indexed: 04/12/2024]
Abstract
Background Accurate preoperative assessment of tumor size is important in developing a surgical plan for breast cancer. The purpose of this study was to evaluate the accuracy of cone-beam breast computed tomography (CBBCT) and magnetic resonance imaging (MRI) in the assessment of tumor size and to analyze the factors influencing the discordance. Methods In this retrospective study, patients with breast cancer who underwent preoperative contrast-enhanced CBBCT (CE-CBBCT) and dynamic contrast-enhanced MRI (DCE-MRI) and received a complete pathologic diagnosis from August 2020 to December 2021 were included, using the pathological result as the gold standard. Two radiologists assessed the CBBCT and MRI features and measured the tumor size with a 2-week washout period. Intraclass correlation coefficient (ICC) and Bland-Altman analyses were used to assess inter-observer reproducibility and agreement based on CBBCT, MRI and pathology. Univariate analyses of differences in clinical, pathological and CBBCT/MRI features between the concordant and discordant groups was performed using the t-test, Mann-Whitney U-test, Chi-squared test and Fisher's exact test. Multivariate analyses were used to identify factors associated with discordance of CBBCT/MRI with pathology. Results A total of 115 female breast cancer patients (115 lesions) were included. All patients had a single malignant tumor of the unilateral breast. The reproducibility and the agreement ranged from moderate to excellent (ICC =0.607-0.983). Receiver operating characteristic (ROC) analyses showed that the cut-off values of CBBCT-pathology and MRI-pathology discordance were 2.25 and 2.65 cm, respectively. CBBCT/MRI-pathology concordance was significantly associated with the extent of pathology, lesion type, presence of calcification, human epidermal growth factor receptor 2 (HER2) status and fatty infiltration (P<0.05). In lesions containing calcification, the difference of CBBCT-pathology was significantly smaller than MRI-pathology (P=0.021). Non-mass enhancement (NME) was the main predictor of CBBCT- or MRI-pathology discordance [odds ratio (OR) =3.293-6.469, P<0.05], and HER2 positivity was a predictor of CBBCT-pathology discordance (OR =3.514, P=0.019). Conclusions CBBCT and MRI have comparable accuracy in measurement of tumor size, and CBBCT is advantageous in assessing the size of calcified lesions. NME and HER2 positivity are significant predictors of CBBCT-pathology discordance. This suggests that CBBCT might serve as an alternative imaging technique to assess tumor size when patients do not tolerate MRI.
Collapse
Affiliation(s)
- Mengran Zhao
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Xiangchao Song
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Yue Ma
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Zhijun Li
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Yafei Wang
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Aidi Liu
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Hong Lu
- Department of Breast Imaging, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Ying Ma
- Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| | - Zhaoxiang Ye
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
| |
Collapse
|
8
|
Boldrini L, D'Aviero A, De Felice F, Desideri I, Grassi R, Greco C, Iorio GC, Nardone V, Piras A, Salvestrini V. Artificial intelligence applied to image-guided radiation therapy (IGRT): a systematic review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO). LA RADIOLOGIA MEDICA 2024; 129:133-151. [PMID: 37740838 DOI: 10.1007/s11547-023-01708-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Accepted: 08/16/2023] [Indexed: 09/25/2023]
Abstract
INTRODUCTION The advent of image-guided radiation therapy (IGRT) has recently changed the workflow of radiation treatments by ensuring highly collimated treatments. Artificial intelligence (AI) and radiomics are tools that have shown promising results for diagnosis, treatment optimization and outcome prediction. This review aims to assess the impact of AI and radiomics on modern IGRT modalities in RT. METHODS A PubMed/MEDLINE and Embase systematic review was conducted to investigate the impact of radiomics and AI to modern IGRT modalities. The search strategy was "Radiomics" AND "Cone Beam Computed Tomography"; "Radiomics" AND "Magnetic Resonance guided Radiotherapy"; "Radiomics" AND "on board Magnetic Resonance Radiotherapy"; "Artificial Intelligence" AND "Cone Beam Computed Tomography"; "Artificial Intelligence" AND "Magnetic Resonance guided Radiotherapy"; "Artificial Intelligence" AND "on board Magnetic Resonance Radiotherapy" and only original articles up to 01.11.2022 were considered. RESULTS A total of 402 studies were obtained using the previously mentioned search strategy on PubMed and Embase. The analysis was performed on a total of 84 papers obtained following the complete selection process. Radiomics application to IGRT was analyzed in 23 papers, while a total 61 papers were focused on the impact of AI on IGRT techniques. DISCUSSION AI and radiomics seem to significantly impact IGRT in all the phases of RT workflow, even if the evidence in the literature is based on retrospective data. Further studies are needed to confirm these tools' potential and provide a stronger correlation with clinical outcomes and gold-standard treatment strategies.
Collapse
Affiliation(s)
- Luca Boldrini
- UOC Radioterapia Oncologica, Fondazione Policlinico Universitario IRCCS "A. Gemelli", Rome, Italy
- Università Cattolica del Sacro Cuore, Rome, Italy
| | - Andrea D'Aviero
- Radiation Oncology, Mater Olbia Hospital, Olbia, Sassari, Italy
| | - Francesca De Felice
- Radiation Oncology, Department of Radiological, Policlinico Umberto I, Rome, Italy
- Oncological and Pathological Sciences, "Sapienza" University of Rome, Rome, Italy
| | - Isacco Desideri
- Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
| | - Roberta Grassi
- Department of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy
| | - Carlo Greco
- Department of Radiation Oncology, Università Campus Bio-Medico di Roma, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | | | - Valerio Nardone
- Department of Precision Medicine, University of Campania "L. Vanvitelli", Naples, Italy
| | - Antonio Piras
- UO Radioterapia Oncologica, Villa Santa Teresa, Bagheria, Palermo, Italy.
| | - Viola Salvestrini
- Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
- Cyberknife Center, Istituto Fiorentino di Cura e Assistenza (IFCA), 50139, Florence, Italy
| |
Collapse
|
9
|
He X, Chen Z, Gao Y, Wang W, You M. Reproducibility and location-stability of radiomic features derived from cone-beam computed tomography: a phantom study. Dentomaxillofac Radiol 2023; 52:20230180. [PMID: 37664997 PMCID: PMC10968769 DOI: 10.1259/dmfr.20230180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2023] [Revised: 07/23/2023] [Accepted: 08/02/2023] [Indexed: 09/05/2023] Open
Abstract
OBJECTIVES This study aims to determine the reproducibility and location-stability of cone-beam computed tomography (CBCT) radiomic features. METHODS Centrifugal tubes with six concentrations of K2HPO4 solutions (50, 100, 200, 400, 600, and 800 mg ml-1) were imaged within a customized phantom. For each concentration, images were captured twice as test and retest sets. Totally, 69 radiomic features were extracted by LIFEx. The reproducibility was assessed between the test and retest sets. We used the concordance correlation coefficient (CCC) to screen qualified features and then compared the differences in the numbers of them under 24 series (four locations groups * six concentrations). The location-stability was assessed using the Kruskal-Wallis test under different concentration sets; likewise, the numbers of qualified features under six test sets were analyzed. RESULTS There were 20 and 23 qualified features in the reproducibility and location-stability experiments, respectively. In the reproducibility experiment, the performance of the peripheral groups and high-concentration sets was significantly better than the center groups and low-concentration sets. The effect of concentration on the location-stability of features was not monotonic, and the number of qualified features in the low-concentration sets was greater than that in the high-concentration sets. No features were qualified in both experiments. CONCLUSIONS The density and location of the target object can affect the number of reproducible radiomic features, and its density can also affect the number of location-stable radiomic features. The problem of feature reliability should be treated cautiously in radiomic research on CBCT.
Collapse
Affiliation(s)
- Xian He
- State Key Laboratory of Oral Diseases,
National Center for Stomatology, National Clinical Research Center for Oral
Diseases, West China School of Stomatology, Sichuan
University, Chengdu,
China
| | - Zhi Chen
- School of Communication and Electronic
Engineering, East China Normal University,
Shanghai, China
| | - Yutao Gao
- School of Computer Science, Sichuan
University, Chengdu,
China
| | - Wanjing Wang
- Faculty of Mathematics, Sichuan
University, Chengdu,
China
| | - Meng You
- Department of Oral Medical Imaging,
State Key Laboratory of Oral Diseases, National Center for Stomatology,
National Clinical Research Center for Oral Diseases, West China Hospital of
Stomatology, Sichuan University,
Chengdu, China
| |
Collapse
|
10
|
Adachi T, Nakamura M, Iramina H, Matsumoto K, Ishihara Y, Tachibana H, Kurokawa S, Cho S, Tanaka K, Fukumoto K, Nishiyama T, Kito S, Mizowaki T. Identification of reproducible radiomic features from on-board volumetric images: A multi-institutional phantom study. Med Phys 2023; 50:5585-5596. [PMID: 36932977 DOI: 10.1002/mp.16376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 02/25/2023] [Accepted: 02/27/2023] [Indexed: 03/19/2023] Open
Abstract
BACKGROUND Radiomics analysis using on-board volumetric images has attracted research attention as a method for predicting prognosis during treatment; however, the lack of standardization is still one of the main concerns. PURPOSE This study investigated the factors that influence the reproducibility of radiomic features extracted from on-board volumetric images using an anthropomorphic radiomics phantom. Furthermore, a phantom experiment was conducted with different treatment machines from multiple institutions as external validation to identify reproducible radiomic features. METHODS The phantom was designed to be 35 × 20 × 20 cm with eight types of heterogeneous spheres (⌀ = 1, 2, and 3 cm). On-board volumetric images were acquired using 15 treatment machines from eight institutions. Of these, kilovoltage cone-beam computed tomography (kV-CBCT) image data acquired from four treatment machines at one institution were used as an internal evaluation dataset to explore the reproducibility of radiomic features. The remaining image data, including kV-CBCT, megavoltage-CBCT (MV-CBCT), and megavoltage computed tomography (MV-CT) provided by seven different institutions (11 treatment machines), were used as an external validation dataset. A total of 1,302 radiomic features, including 18 first-order, 75 texture, 465 (i.e., 93 × 5) Laplacian of Gaussian (LoG) filter-based, and 744 (i.e., 93 × 8) wavelet filter-based features, were extracted within the spheres. The intraclass correlation coefficient (ICC) was calculated to explore feature repeatability and reproducibility using an internal evaluation dataset. Subsequently, the coefficient of variation (COV) was calculated to validate the feature variability of external institutions. An absolute ICC exceeding 0.85 or COV under 5% was considered indicative of a highly reproducible feature. RESULTS For internal evaluation, ICC analysis showed that the median percentage of radiomic features with high repeatability was 95.2%. The ICC analysis indicated that the median percentages of highly reproducible features for inter-tube current, reconstruction algorithm, and treatment machine were decreased by 20.8%, 29.2%, and 33.3%, respectively. For external validation, the COV analysis showed that the median percentage of reproducible features was 31.5%. A total of 16 features, including nine LoG filter-based and seven wavelet filter-based features, were indicated as highly reproducible features. The gray-level run-length matrix (GLRLM) was classified as containing the most frequent features (N = 8), followed by the gray-level dependence matrix (N = 7) and gray-level co-occurrence matrix (N = 1) features. CONCLUSIONS We developed the standard phantom for radiomics analysis of kV-CBCT, MV-CBCT, and MV-CT images. With this phantom, we revealed that the differences in the treatment machine and image reconstruction algorithm reduce the reproducibility of radiomic features from on-board volumetric images. Specifically, the most reproducible features for external validation were LoG or wavelet filter-based GLRLM features. However, the acceptability of the identified features should be examined in advance at each institution before applying the findings to prognosis prediction.
Collapse
Affiliation(s)
- Takanori Adachi
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Shogoin, Sakyo-ku, Kyoto, Japan
| | - Mitsuhiro Nakamura
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Shogoin, Sakyo-ku, Kyoto, Japan
- Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Shogoin, Sakyo-ku, Kyoto, Japan
| | - Hiraku Iramina
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Shogoin, Sakyo-ku, Kyoto, Japan
| | - Kazushige Matsumoto
- Department of Radiology, National Hospital Organization Kyoto Medical Center, Fushimi-ku, Kyoto, Japan
| | - Yoshitomo Ishihara
- Department of Radiation Oncology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan
| | - Hidenobu Tachibana
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | - Shogo Kurokawa
- Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan
| | - SangYong Cho
- Division of Radiation Oncology, Chiba Cancer Center, Chuo-ku, Chiba, Japan
| | - Kazunori Tanaka
- Department of Radiation Oncology, Kyoto City Hospital, Nakagyo-ku, Kyoto, Japan
| | - Kenta Fukumoto
- Department of Radiation Oncology, Kyoto City Hospital, Nakagyo-ku, Kyoto, Japan
| | - Tomohiro Nishiyama
- Department of Radiation Oncology, Kyoto-Katsura Hospital, Nishikyo-ku, Kyoto, Japan
| | - Satoshi Kito
- Department of Radiotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan
| | - Takashi Mizowaki
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Shogoin, Sakyo-ku, Kyoto, Japan
| |
Collapse
|
11
|
Brown KH, Payan N, Osman S, Ghita M, Walls GM, Patallo IS, Schettino G, Prise KM, McGarry CK, Butterworth KT. Development and optimisation of a preclinical cone beam computed tomography-based radiomics workflow for radiation oncology research. Phys Imaging Radiat Oncol 2023; 26:100446. [PMID: 37252250 PMCID: PMC10213103 DOI: 10.1016/j.phro.2023.100446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 05/03/2023] [Accepted: 05/08/2023] [Indexed: 05/31/2023] Open
Abstract
Background and purpose Radiomics features derived from medical images have the potential to act as imaging biomarkers to improve diagnosis and predict treatment response in oncology. However, the complex relationships between radiomics features and the biological characteristics of tumours are yet to be fully determined. In this study, we developed a preclinical cone beam computed tomography (CBCT) radiomics workflow with the aim to use in vivo models to further develop radiomics signatures. Materials and methods CBCT scans of a mouse phantom were acquired using onboard imaging from a small animal radiotherapy research platform (SARRP, Xstrahl). The repeatability and reproducibility of radiomics outputs were compared across different imaging protocols, segmentation sizes, pre-processing parameters and materials. Robust features were identified and used to compare scans of two xenograft mouse tumour models (A549 and H460). Results Changes to the radiomics workflow significantly impact feature robustness. Preclinical CBCT radiomics analysis is feasible with 119 stable features identified from scans imaged at 60 kV, 25 bin width and 0.26 mm slice thickness. Large variation in segmentation volumes reduced the number of reliable radiomics features for analysis. Standardization in imaging and analysis parameters is essential in preclinical radiomics analysis to improve accuracy of outputs, leading to more consistent and reproducible findings. Conclusions We present the first optimised workflow for preclinical CBCT radiomics to identify imaging biomarkers. Preclinical radiomics has the potential to maximise the quantity of data captured in in vivo experiments and could provide key information supporting the wider application of radiomics.
Collapse
Affiliation(s)
- Kathryn H. Brown
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
| | - Neree Payan
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
| | - Sarah Osman
- University College London Hospitals NHS Foundation Trust Department of Radiotherapy, London, UK
| | - Mihaela Ghita
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
| | - Gerard M. Walls
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
- Cancer Centre, Belfast Health & Social Care Trust, Lisburn Road, Belfast BT9 7AB, Northern Ireland, UK
| | | | | | - Kevin M. Prise
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
| | - Conor K. McGarry
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
- Cancer Centre, Belfast Health & Social Care Trust, Lisburn Road, Belfast BT9 7AB, Northern Ireland, UK
| | - Karl T. Butterworth
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Northern Ireland, UK
| |
Collapse
|
12
|
Hung KF, Ai QYH, Wong LM, Yeung AWK, Li DTS, Leung YY. Current Applications of Deep Learning and Radiomics on CT and CBCT for Maxillofacial Diseases. Diagnostics (Basel) 2022; 13:110. [PMID: 36611402 PMCID: PMC9818323 DOI: 10.3390/diagnostics13010110] [Citation(s) in RCA: 29] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Revised: 12/23/2022] [Accepted: 12/24/2022] [Indexed: 12/31/2022] Open
Abstract
The increasing use of computed tomography (CT) and cone beam computed tomography (CBCT) in oral and maxillofacial imaging has driven the development of deep learning and radiomics applications to assist clinicians in early diagnosis, accurate prognosis prediction, and efficient treatment planning of maxillofacial diseases. This narrative review aimed to provide an up-to-date overview of the current applications of deep learning and radiomics on CT and CBCT for the diagnosis and management of maxillofacial diseases. Based on current evidence, a wide range of deep learning models on CT/CBCT images have been developed for automatic diagnosis, segmentation, and classification of jaw cysts and tumors, cervical lymph node metastasis, salivary gland diseases, temporomandibular (TMJ) disorders, maxillary sinus pathologies, mandibular fractures, and dentomaxillofacial deformities, while CT-/CBCT-derived radiomics applications mainly focused on occult lymph node metastasis in patients with oral cancer, malignant salivary gland tumors, and TMJ osteoarthritis. Most of these models showed high performance, and some of them even outperformed human experts. The models with performance on par with human experts have the potential to serve as clinically practicable tools to achieve the earliest possible diagnosis and treatment, leading to a more precise and personalized approach for the management of maxillofacial diseases. Challenges and issues, including the lack of the generalizability and explainability of deep learning models and the uncertainty in the reproducibility and stability of radiomic features, should be overcome to gain the trust of patients, providers, and healthcare organizers for daily clinical use of these models.
Collapse
Affiliation(s)
- Kuo Feng Hung
- Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China
| | - Qi Yong H. Ai
- Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Lun M. Wong
- Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
| | - Andy Wai Kan Yeung
- Oral and Maxillofacial Radiology, Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China
| | - Dion Tik Shun Li
- Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China
| | - Yiu Yan Leung
- Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong SAR, China
| |
Collapse
|
13
|
Jensen LJ, Kim D, Elgeti T, Steffen IG, Schaafs LA, Hamm B, Nagel SN. Enhancing the stability of CT radiomics across different volume of interest sizes using parametric feature maps: a phantom study. Eur Radiol Exp 2022; 6:43. [PMID: 36104519 PMCID: PMC9474978 DOI: 10.1186/s41747-022-00297-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2022] [Accepted: 07/05/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND In radiomics studies, differences in the volume of interest (VOI) are often inevitable and may confound the extracted features. We aimed to correct this confounding effect of VOI variability by applying parametric maps with a fixed voxel size. METHODS Ten scans of a cup filled with sodium chloride solution were scanned using a multislice computed tomography (CT) unit. Sphere-shaped VOIs with different diameters (4, 8, or 16 mm) were drawn centrally into the phantom. A total of 93 features were extracted conventionally from the original images using PyRadiomics. Using a self-designed and pretested software tool, parametric maps for the same 93 features with a fixed voxel size of 4 mm3 were created. To retrieve the feature values from the maps, VOIs were copied from the original images to preserve the position. Differences in feature quantities between the VOI sizes were tested with the Mann-Whitney U-test and agreement with overall concordance correlation coefficients (OCCC). RESULTS Fifty-five conventionally extracted features were significantly different between the VOI sizes, and none of the features showed excellent agreement in terms of OCCCs. When read from the parametric maps, only 8 features showed significant differences, and 3 features showed an excellent OCCC (≥ 0.85). The OCCCs for 89 features substantially increased using the parametric maps. CONCLUSIONS This phantom study shows that converting CT images into parametric maps resolves the confounding effect of VOI variability and increases feature reproducibility across VOI sizes.
Collapse
Affiliation(s)
- Laura J Jensen
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
| | - Damon Kim
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
| | - Thomas Elgeti
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - Ingo G Steffen
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - Lars-Arne Schaafs
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - Bernd Hamm
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - Sebastian N Nagel
- Klinik für Radiologie, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany
| |
Collapse
|